Justice Samuel Alito’s abortion ruling overturning Roe v. Wade remained largely unchanged from the version leaked to the public in May—but in responding to the dissent and concurring opinion by Chief Justice John Roberts, Alito did add some important new elements to the decision.

The Paul Hastings leadership transition in October will test whether Frank Lopez as a newcomer can build on the growth record of Seth Zachary, who has led the Los Angeles-founded firm through almost a third of its 70-year existence.

Goldman Sachs CEO David Solomon and General Motors CEO Mary Barra are among the top executives who’ve met with SEC Chair Gary Gensler over his agency’s plan to make companies disclose indirect greenhouse gas emissions as part of new climate reporting rules.

Firms that struggled to hire enough US-born workers in science, technology, engineering, and mathematics fields even before an unprecedented labor shortage have come to rely on colleges and grad programs to find skilled foreign workers. An enrollment dip from outside the country will put an even bigger squeeze on recruitment.

Large companies that spend billions of dollar a year on prescription drugs for their employees are hoping that the Federal Trade Commission’s inquiry into pharmaceutical benefit manager business practices will yield information that spurs major policy changes to reduce drug prices.

Industry groups are pushing back on legislation in North Carolina and other states that would require companies that produce PFAS to pay for cleanup and other costs. Advocates for the bills say success in Vermont could be a model for other states.